vs
Side-by-side financial comparison of Autolus Therapeutics plc (AUTL) and KKR Real Estate Finance Trust Inc. (KREF). Click either name above to swap in a different company.
KKR Real Estate Finance Trust Inc. is the larger business by last-quarter revenue ($25.8M vs $21.2M, roughly 1.2× Autolus Therapeutics plc). KKR Real Estate Finance Trust Inc. runs the higher net margin — -101.7% vs -373.3%, a 271.6% gap on every dollar of revenue.
Autolus Therapeutics plc is a clinical-stage biopharmaceutical company specializing in the development of next-generation engineered chimeric antigen receptor T-cell (CAR-T) therapies for the treatment of hematological malignancies and solid tumors. It operates in the global oncology biotech market, advancing a pipeline of targeted immunotherapy candidates across multiple clinical development stages.
KKR Real Estate Finance Trust Inc. is a specialized real estate finance firm sponsored by global investment firm KKR. It primarily originates, acquires, and manages a portfolio of senior secured commercial real estate loans, mostly backed by high-quality institutional commercial properties across the United States, delivering stable risk-adjusted returns to investors via interest income from its diversified assets.
AUTL vs KREF — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.2M | $25.8M |
| Net Profit | $-79.1M | $-26.2M |
| Gross Margin | — | — |
| Operating Margin | -337.9% | -105.1% |
| Net Margin | -373.3% | -101.7% |
| Revenue YoY | — | -26.6% |
| Net Profit YoY | 3.6% | -229.6% |
| EPS (diluted) | $-0.30 | $-0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $25.8M | ||
| Q3 25 | $21.2M | $25.3M | ||
| Q2 25 | $20.9M | $30.2M | ||
| Q1 25 | $9.0M | $31.3M | ||
| Q4 24 | — | $35.1M | ||
| Q3 24 | $0 | $37.0M | ||
| Q2 24 | $0 | $40.4M | ||
| Q1 24 | $10.1M | $39.1M |
| Q4 25 | — | $-26.2M | ||
| Q3 25 | $-79.1M | $13.8M | ||
| Q2 25 | $-47.9M | $-29.7M | ||
| Q1 25 | $-70.2M | $-4.9M | ||
| Q4 24 | — | $20.3M | ||
| Q3 24 | $-82.1M | $-7.4M | ||
| Q2 24 | $-58.3M | $25.8M | ||
| Q1 24 | $-52.7M | $-3.1M |
| Q4 25 | — | -105.1% | ||
| Q3 25 | -337.9% | 50.4% | ||
| Q2 25 | -292.6% | -101.3% | ||
| Q1 25 | -726.3% | -18.3% | ||
| Q4 24 | — | 55.8% | ||
| Q3 24 | — | -19.6% | ||
| Q2 24 | — | 63.3% | ||
| Q1 24 | -384.1% | -8.7% |
| Q4 25 | — | -101.7% | ||
| Q3 25 | -373.3% | 54.4% | ||
| Q2 25 | -229.0% | -98.5% | ||
| Q1 25 | -781.1% | -15.5% | ||
| Q4 24 | — | 57.7% | ||
| Q3 24 | — | -20.0% | ||
| Q2 24 | — | 63.9% | ||
| Q1 24 | -522.1% | -7.9% |
| Q4 25 | — | $-0.49 | ||
| Q3 25 | $-0.30 | $0.12 | ||
| Q2 25 | $-0.18 | $-0.53 | ||
| Q1 25 | $-0.26 | $-0.15 | ||
| Q4 24 | — | $0.22 | ||
| Q3 24 | $-0.31 | $-0.19 | ||
| Q2 24 | $-0.22 | $0.29 | ||
| Q1 24 | $-0.24 | $-0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.1M | $84.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $265.5M | $1.2B |
| Total Assets | $661.9M | $6.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $84.6M | ||
| Q3 25 | $86.1M | $204.1M | ||
| Q2 25 | $123.8M | $107.7M | ||
| Q1 25 | $95.8M | $106.4M | ||
| Q4 24 | — | $104.9M | ||
| Q3 24 | $657.1M | $108.8M | ||
| Q2 24 | $705.9M | $107.2M | ||
| Q1 24 | $758.5M | $106.5M |
| Q4 25 | — | $1.2B | ||
| Q3 25 | $265.5M | $1.2B | ||
| Q2 25 | $346.5M | $1.2B | ||
| Q1 25 | $371.1M | $1.3B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | $477.0M | $1.4B | ||
| Q2 24 | $527.8M | $1.4B | ||
| Q1 24 | $582.0M | $1.4B |
| Q4 25 | — | $6.5B | ||
| Q3 25 | $661.9M | $6.5B | ||
| Q2 25 | $721.0M | $6.8B | ||
| Q1 25 | $746.3M | $6.6B | ||
| Q4 24 | — | $6.4B | ||
| Q3 24 | $827.5M | $6.8B | ||
| Q2 24 | $853.6M | $7.1B | ||
| Q1 24 | $901.4M | $7.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-67.9M | $72.3M |
| Free Cash FlowOCF − Capex | $-72.3M | — |
| FCF MarginFCF / Revenue | -341.2% | — |
| Capex IntensityCapex / Revenue | 20.8% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-322.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $72.3M | ||
| Q3 25 | $-67.9M | $18.5M | ||
| Q2 25 | $-72.8M | $21.1M | ||
| Q1 25 | $-75.6M | $15.9M | ||
| Q4 24 | — | $132.6M | ||
| Q3 24 | $-76.7M | $49.1M | ||
| Q2 24 | $-51.1M | $30.6M | ||
| Q1 24 | $-40.5M | $34.5M |
| Q4 25 | — | — | ||
| Q3 25 | $-72.3M | — | ||
| Q2 25 | $-80.1M | — | ||
| Q1 25 | $-83.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-86.3M | — | ||
| Q2 24 | $-51.9M | — | ||
| Q1 24 | $-41.0M | — |
| Q4 25 | — | — | ||
| Q3 25 | -341.2% | — | ||
| Q2 25 | -382.6% | — | ||
| Q1 25 | -933.1% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -406.8% | — |
| Q4 25 | — | — | ||
| Q3 25 | 20.8% | — | ||
| Q2 25 | 34.8% | — | ||
| Q1 25 | 91.8% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 5.3% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.34× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 6.54× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 1.19× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
